Related Experiment Video
Updated: Jul 14, 2026

Laboratory Administration of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS): Technique, Targeting, and Considerations
Published on: January 7, 2019
Central therapeutic effects of peripheral vagus nerve stimulation
Margaret Gross1, Monisha Goyal
1School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Abstract:
Despite the recent addition of more than ten new antiepileptic drugs on the market, epilepsy remains poorly controlled in almost 30% of patients. For this subgroup of patients with pharmacoresistant epilepsy, vagus nerve stimulation (VNS) has become a viable option. More recently, it has also shown promise in treatment-resistant depression. This article discusses VNS's history, current applications, and potential to treat chronic neurologic and psychiatric disorders.
Related Concept Videos
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Motor Unit Stimulation
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...

